← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2020Last known activity
Dec 1, 2025
Timeline
2010s
- Jan 1, 2015
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network— Founded
Drugs by trial phase (7 distinct, 7 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT07228663CollaboratorPhase 3Dec 1, 2025
- NCT06452342CollaboratorPhase 4Jun 30, 2024
- NCT05920343CollaboratorPhase 2/Phase 3Feb 29, 2024
- NCT05848713CollaboratorPhase 3Oct 10, 2023
- NCT04642430CollaboratorPhase 4Jan 29, 2021
- NCT04243122CollaboratorPhase 2Feb 15, 2020
- NCT04153760CollaboratorEarly Phase 1Jan 31, 2020
Details
- Founded
- Montreal, CA Jan 1, 2015
- Last known activity
- Dec 1, 2025